[go: up one dir, main page]

DE60027894D1 - Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen - Google Patents

Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen

Info

Publication number
DE60027894D1
DE60027894D1 DE60027894T DE60027894T DE60027894D1 DE 60027894 D1 DE60027894 D1 DE 60027894D1 DE 60027894 T DE60027894 T DE 60027894T DE 60027894 T DE60027894 T DE 60027894T DE 60027894 D1 DE60027894 D1 DE 60027894D1
Authority
DE
Germany
Prior art keywords
infections
inflammation
prevention
treatment
acid bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60027894T
Other languages
English (en)
Other versions
DE60027894T2 (de
Inventor
Simone Claudio De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actial Farmaceutica Ltda
Original Assignee
Actial Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmaceutica Ltda filed Critical Actial Farmaceutica Ltda
Application granted granted Critical
Publication of DE60027894D1 publication Critical patent/DE60027894D1/de
Publication of DE60027894T2 publication Critical patent/DE60027894T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/855—Lactobacillus brevis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
DE60027894T 1999-06-21 2000-06-16 Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen Expired - Lifetime DE60027894T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM990400 1999-06-21
IT1999RM000400A IT1306716B1 (it) 1999-06-21 1999-06-21 Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
PCT/IT2000/000251 WO2000078322A2 (en) 1999-06-21 2000-06-16 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions

Publications (2)

Publication Number Publication Date
DE60027894D1 true DE60027894D1 (de) 2006-06-14
DE60027894T2 DE60027894T2 (de) 2006-11-16

Family

ID=11406844

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60027894T Expired - Lifetime DE60027894T2 (de) 1999-06-21 2000-06-16 Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen

Country Status (35)

Country Link
US (1) US7052688B2 (de)
EP (1) EP1194525B1 (de)
JP (3) JP4949580B2 (de)
KR (1) KR100712286B1 (de)
CN (1) CN1227354C (de)
AR (2) AR024579A1 (de)
AT (1) ATE325614T1 (de)
AU (1) AU775452B2 (de)
BR (2) BRPI0017622B1 (de)
CA (1) CA2373375C (de)
CZ (1) CZ298682B6 (de)
DE (1) DE60027894T2 (de)
DK (1) DK1194525T3 (de)
DZ (1) DZ3167A1 (de)
EA (1) EA006037B1 (de)
EE (1) EE04620B1 (de)
ES (1) ES2262522T3 (de)
HK (1) HK1047132B (de)
HU (1) HUP0202051A3 (de)
IL (2) IL146889A0 (de)
IN (1) IN2001KO01233A (de)
IS (1) IS6177A (de)
IT (1) IT1306716B1 (de)
MA (1) MA25775A1 (de)
MX (1) MX236443B (de)
NO (1) NO329324B1 (de)
NZ (1) NZ516022A (de)
PL (1) PL352805A1 (de)
PT (1) PT1194525E (de)
SI (1) SI1194525T1 (de)
SK (1) SK17172001A3 (de)
TR (1) TR200103606T2 (de)
UA (1) UA76696C2 (de)
WO (1) WO2000078322A2 (de)
ZA (1) ZA200200461B (de)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
HU227086B1 (en) * 1999-11-25 2010-06-28 Vakcina Kft Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
JP4603116B2 (ja) * 1999-12-02 2010-12-22 わかもと製薬株式会社 乳酸菌含有組成物、医薬及び食品
SE518097C2 (sv) * 2000-10-03 2002-08-27 Ellen Ab Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
KR100484480B1 (ko) * 2001-05-04 2005-04-20 정 호 김 표면 막처리된 락토바실러스 퍼멘텀 yl-3 캡슐
EP1287745A1 (de) 2001-08-24 2003-03-05 The Procter & Gamble Company Kaubare Zusammmensetzung mit Probiotika
US20040241149A1 (en) * 2001-09-05 2004-12-02 Claudio De Simone Use of unmethylatd cpg
JP4528472B2 (ja) * 2001-11-29 2010-08-18 ビオフェルミン製薬株式会社 歯周病の予防または治療剤
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections
KR100458008B1 (ko) * 2002-12-02 2004-11-18 대한민국 가축 생산성 향상 유산균
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
EP1481681A1 (de) * 2003-05-30 2004-12-01 Claudio De Simone Milchsäurebakterienkombination und deren Zusammensetzungen
US7384628B2 (en) * 2003-06-23 2008-06-10 Agtech Products, Inc. Lactic acid bacteria and its use in direct-fed microbials
PL1659885T3 (pl) * 2003-08-11 2013-06-28 Oragenics Inc Kompozycje do utrzymania zdrowia jamy ustnej
EP1506781B1 (de) * 2003-11-03 2005-02-23 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
WO2005085287A1 (en) * 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
RU2274447C1 (ru) * 2004-08-04 2006-04-20 Государственное образовательное учреждение высшего профессионального образования "Южно-Уральский государственный университет" Способ лечения герпетической отоинфекции
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
EP1827284B1 (de) * 2004-12-23 2013-08-07 ACTIAL Farmaceutica Lda. Vorrichtung und verfahren zur identifizierung von vaginalen erkrankungen
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
KR20080045706A (ko) * 2005-09-13 2008-05-23 바스프 에스이 액와부 악취 형성을 억제하는 미생물
JP5020245B2 (ja) * 2005-09-19 2012-09-05 ビーエーエスエフ ソシエタス・ヨーロピア 足臭の形成を阻害する微生物
US7563758B2 (en) * 2005-10-06 2009-07-21 E. I. Du Pont De Nemours And Company Enzymatic production of peracids using Lactobacilli having perhydrolysis activity
HUE030542T2 (en) * 2005-10-06 2017-05-29 Probi Ab Use of Lactobacillus to treat viral infections
CN100556414C (zh) * 2005-10-14 2009-11-04 德阳创新生物工程有限公司 一种具免疫调节功能的多菌组合物及其制备方法与用途
ES2417132T3 (es) * 2006-12-19 2013-08-06 Basf Se Usos y métodos para prevenir y/o tratar caries causadas por mutans Streptococci
US20110020283A1 (en) * 2007-02-22 2011-01-27 Schrezenmeir Juergen Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans
WO2009021585A1 (en) * 2007-08-13 2009-02-19 Dsm Ip Assets B.V. Probiotic bacteria for rducing the occurence of symptoms of winter infections
KR100898491B1 (ko) * 2007-10-10 2009-05-19 주식회사한국야쿠르트 사람의 구강 충치균에 저해능이 있는 스트렙토코커스써머필러스 에이취와이9012 및 이를 이용한 식품
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2133414A1 (de) 2008-06-11 2009-12-16 Basf Se Anwendungen und Verfahren zur Vorbeugung und/oder Behandlung von Mundgeruch
US9636196B2 (en) * 2008-06-13 2017-05-02 ProBiora Health, LLC Use of hydrogen peroxide-producing bacteria for tooth whitening
RU2398576C1 (ru) * 2009-01-11 2010-09-10 Владимир Иванович Семенников Способ лечения слюннокаменной болезни
KR101100043B1 (ko) 2009-06-29 2011-12-29 주식회사한국야쿠르트 항염증 효능을 갖는 락토바실러스 플란타룸 에이취와이7711 및 이를 유효성분으로 함유하는 제품
WO2011003062A2 (en) * 2009-07-03 2011-01-06 James Madison University Probiotic compositions and processes thereof
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
DE202009011379U1 (de) * 2009-08-24 2010-12-30 Khalifa, Samir Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch
JP4942831B2 (ja) 2010-03-19 2012-05-30 株式会社キティー 抗アレルギー用組成物
KR101062779B1 (ko) 2010-04-28 2011-09-06 삼육대학교산학협력단 충치 유발 세균의 성장 억제 활성을 나타내는 비피도박테리움 아돌레센티스 ｓｐｍ1005 균주 및 상기 비피도박테리움 아돌레센티스 ｓｐｍ1005 균주 또는 이의 배양물을 유효 성분으로 하는 충치 예방용 식품 및 약제학 조성물
KR101068079B1 (ko) * 2010-07-12 2011-09-28 삼육대학교산학협력단 단순포진바이러스에 대한 항바이러스 활성을 갖는 비피도박테리움 아돌레센티스 ｓｐｍ 0214 및 상기 비피도박테리움 아돌레센티스 ｓｐｍ 0214 균주 또는 이의 배양물을 유효 성분으로 함유하는 단순 포진 바이러스 감염의 예방 또는 치료용 조성물
EP2420580A1 (de) * 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotische Zusammensetzung für die orale Gesundheit
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
KR101900992B1 (ko) * 2011-08-05 2018-09-20 가부시키가이샤 야쿠르트 혼샤 구강 내 질환의 예방 또는 치료제
FR2981273B1 (fr) * 2011-10-14 2013-12-20 Gilles Andre Yves Bhat Nouvelle composition pour les muqueuses: tocopherol, macerat huileux de fleurs de calendula dans de l'huile de rose musquee, palmitate de retinol, ubiquinone, ascorbyl palmitate et lactobacillus
RU2577994C1 (ru) * 2011-11-30 2016-03-20 Компани Жервэ Данон Реутерин-вырабатывающие lactobacillus brevis
RU2494724C2 (ru) * 2012-01-13 2013-10-10 Владимир Николаевич Иванов Зубная паста, содержащая лиофилизированную массу живых бифидобактерий
WO2013155370A1 (en) * 2012-04-13 2013-10-17 The Regents Of The University Of California Sinusitis diagnostics and treatments
KR101506995B1 (ko) * 2012-05-25 2015-03-30 (주)비타바이오 오리나무 수피 추출물 및 유산균을 포함하는 항우식성 조성물
CN102690768B (zh) * 2012-05-31 2014-07-30 江南大学 一株短乳杆菌及其应用
FR2992973B1 (fr) * 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
CN102727531A (zh) * 2012-07-23 2012-10-17 郑州金森生物科技工程有限公司 一种对阴道炎具有治疗和预防作用的活性乳酸菌胶囊
RU2504580C1 (ru) * 2012-08-01 2014-01-20 Вячеслав Михайлович Абрамов ПРОБИОТИЧЕСКИЕ ШТАММЫ Lactobacillus И ИХ КОНСОРЦИУМ ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ УРОГЕНИТАЛЬНЫХ ИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ У ЖЕНЩИН
WO2014064488A1 (en) * 2012-10-25 2014-05-01 Compagnie Gervais Danone Streptococcus thermophilus strains for treating helicobacter pylori infection
CN103409334B (zh) * 2013-01-16 2018-07-20 生合生物科技股份有限公司 抑制阴道炎病原菌之乳酸杆菌及其用途
WO2014127066A1 (en) * 2013-02-14 2014-08-21 University Of Florida Research Foundation, Inc. Probiotic arginolytic oral compositions and methods of making and using probiotic arginolytic oral compositions
US10206959B2 (en) 2013-02-14 2019-02-19 University Of Florida Research Foundation, Inc. Probiotic arginolytic oral compositions and methods of making and using probiotic arginolytic oral compositions
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
AU2014302735B2 (en) 2013-06-27 2016-12-15 Starbucks Corporation D/B/A Starbucks Coffee Company Biopreservation methods for beverages and other foods
US10857090B2 (en) * 2013-07-05 2020-12-08 Stellar Biome Inc. Oral compositions
CN104957260B (zh) * 2014-03-07 2018-07-24 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
CN104232537B (zh) * 2014-09-03 2017-04-12 中国科学院微生物研究所 一株弯曲乳杆菌及其应用
CN104293718B (zh) * 2014-10-11 2017-01-18 中国科学院微生物研究所 一株詹氏乳杆菌及其应用
CN104694414B (zh) * 2014-11-21 2019-05-24 北京百益恒源科技有限公司 一株詹氏乳酸杆菌(Lactobacillus jensenii)及其制药用途
CN104622914A (zh) * 2015-01-06 2015-05-20 占美华 阴道益生菌栓
KR101980252B1 (ko) 2015-05-26 2019-05-21 (주)투라인스 질증 치료용 조성물
RU2619281C2 (ru) * 2015-07-24 2017-05-15 Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт технологии консервирования Способ выработки ферментированного растительного сырья
JP6957452B2 (ja) * 2015-08-25 2021-11-02 イムネバイオテック・メディカル・スウェーデン・エービー 腸の感染症及び炎症の治療及び予防のための組成物及び方法
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
CN105362296A (zh) * 2015-11-27 2016-03-02 成都吉氧屋科技有限公司 乳酸菌洗鼻液
GB201600975D0 (en) 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof
EP3196318A1 (de) 2016-01-19 2017-07-26 Symrise AG Probiotika zum ändern der zusammensetzung von oralen biofilmen
EP3405205B1 (de) * 2016-01-19 2020-07-15 Symrise AG Probiotika zur verwendung als entzündungshemmende wirkstoffe in der mundhöhle
FR3048361B1 (fr) * 2016-03-01 2020-12-18 Biose Compositions pour le traitement des candidoses
KR101720145B1 (ko) * 2016-07-08 2017-04-07 (주)정가진면역연구소 여성 질염 예방 및 개선 기능성 조성물
EP3351259A1 (de) 2017-01-18 2018-07-25 Symrise AG Probiotika zur aggregation mit krankheitsassoziierten spezies in der mundhöhle
EP3517119B1 (de) * 2018-01-26 2021-08-11 Probisearch, S.L.U. Zusammensetzung mit neuem lactobacillus salivarius-stamm und verfahren zur vorbeugung und behandlung von ohrenentzündung und infektionen der oberen atemwege
RU2675110C1 (ru) * 2018-04-09 2018-12-17 Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) Фармацевтическая композиция для терапии воспалительных заболеваний слизистых оболочек кишечника на основе штамма Lactobacillus brevis 47f, проявляющая местную противовоспалительную активность
CN112469812B (zh) * 2018-05-23 2024-01-12 Ko生物技术有限公司 格氏乳杆菌kbl697菌株及其用途
NZ770210A (en) * 2018-05-23 2024-03-22 Ko Biolabs Inc Lactobacillus crispatus kbl693 strain and use thereof
WO2019227417A1 (zh) * 2018-05-31 2019-12-05 深圳华大生命科学研究院 一种组合物及其应用
WO2020001747A1 (en) 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
KR102063554B1 (ko) 2018-09-12 2020-01-09 (주)성운파마코피아 항진균 활성 또는 항균 활성을 갖는 락토바실러스 가세리 swpm102
KR102164906B1 (ko) * 2018-09-12 2020-10-14 (주)성운파마코피아 락토바실러스 살리바리우스 swpm101 및 락토바실러스 가세리 swpm102를 포함하는 골질환의 예방, 개선 또는 치료용 조성물
WO2020073088A1 (en) * 2018-10-10 2020-04-16 Servatus Ltd Methods of treatment of inflammatory conditions and associated infections
CN111088178B (zh) * 2018-10-23 2022-11-22 上海上药信谊药厂有限公司 一种产乳酸和h2o2的乳杆菌及其应用
EP3952848A1 (de) 2019-04-09 2022-02-16 Dermbiont, Inc. Zusammensetzungen und verfahren zur verbesserung der gesundheit und zur behandlung und vorbeugung von mit pathogenen keimen assoziierten krankheiten, störungen und zuständen
IT201900023142A1 (it) * 2019-12-05 2021-06-05 Sifi Spa Composizione topica oculare contenente metaboliti della fermentazione di lactobacillus
KR102364448B1 (ko) * 2019-12-31 2022-02-17 심민보 프로바이오틱스 및 항생제를 포함하는 항염증용 약학적 조성물 및 이를 이용한 방법
KR102162470B1 (ko) 2020-03-19 2020-10-06 주식회사 비피도 비피도박테리움 슈도카테눌라튬 c-rapo (kctc13986bp), 비피도박테리움 비피덤 att (kctc13474bp) 균주를 포함하는 쇼그렌증후군 억제용 식품 조성물 및 약학 조성물
CN111548970B (zh) * 2020-05-29 2021-03-26 江南大学 一株能够预防和/或治疗幽门螺杆菌感染的卷曲乳杆菌
CN111617025B (zh) * 2020-06-12 2021-01-29 广州市千邦化妆品有限公司 美白祛斑抗糖化的发酵产物化妆品
CN113082149A (zh) * 2021-04-28 2021-07-09 宋颖鹰 植物草本益生菌口腔含片及其制备方法
KR102646766B1 (ko) * 2023-06-14 2024-03-13 일동바이오사이언스(주) 잇몸 질환을 예방하고 구취 생성 억제능을 가지는 비피도박테리움 브레베 idcc 4401 균주를 포함하는 조성물 및 건강기능식품
CN117535209B (zh) * 2024-01-04 2024-03-29 四川厌氧生物科技有限责任公司 左旋短乳杆菌及其在女性生殖道健康中的应用
CN118542885A (zh) * 2024-04-08 2024-08-27 杭州核力欣健实业股份有限公司 一种乳酸菌二联活菌制剂、其制备方法及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60190707A (ja) * 1984-03-09 1985-09-28 Advance Res & Dev Co Ltd 抗う蝕剤
JPS6191126A (ja) * 1984-10-09 1986-05-09 Advance Res & Dev Co Ltd 抗歯周症剤
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5286478A (en) * 1987-11-04 1994-02-15 Rhone-Poulenc Chimie Dentifrice-compatible silica particulates
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
IT1254210B (it) * 1992-02-10 1995-09-14 Simone Claudio De Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
RU2031586C1 (ru) * 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
CA2157904A1 (en) * 1993-03-10 1994-09-15 Mary Anna Williamson Biocontrol agents for use in agriculture
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
EP0684307B1 (de) * 1994-05-27 1999-12-15 Agrano Ag Verfahren zur Herstellung von Kulturmedien, welche für die individuelle Kultur von Hefen und Milchsäurebakterien oder die Kokultur von Hefen und Milchsäurebakterien verwendbar sind.
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
JPH08298982A (ja) * 1995-05-02 1996-11-19 Aasu Giken:Kk 複合微生物製剤
EP0880354A1 (de) * 1996-02-14 1998-12-02 The Procter & Gamble Company Urogenitale und intestinale zubereitungen
JP4021951B2 (ja) * 1996-03-01 2007-12-12 わかもと製薬株式会社 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia-Yomo S.P.A., Mailand/Milano Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
JP3028214B2 (ja) * 1997-06-03 2000-04-04 カルピス株式会社 鳥類用生菌剤の投与方法
KR100266752B1 (ko) * 1997-08-07 2001-03-02 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
ATE207755T1 (de) * 1998-04-30 2001-11-15 Vesely Renata Maria Cavaliere Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.

Also Published As

Publication number Publication date
BR0011799A (pt) 2002-03-12
NO20016291D0 (no) 2001-12-20
NO329324B1 (no) 2010-09-27
CZ298682B6 (cs) 2007-12-19
CN1357038A (zh) 2002-07-03
IT1306716B1 (it) 2001-10-02
CZ20014220A3 (cs) 2002-04-17
DE60027894T2 (de) 2006-11-16
IS6177A (is) 2001-11-27
PT1194525E (pt) 2006-09-29
US20020094328A1 (en) 2002-07-18
SI1194525T1 (sl) 2006-10-31
KR20020033643A (ko) 2002-05-07
JP2003502375A (ja) 2003-01-21
KR100712286B1 (ko) 2007-04-27
EP1194525B1 (de) 2006-05-10
JP2012110334A (ja) 2012-06-14
MX236443B (es) 2006-05-03
HUP0202051A2 (hu) 2003-01-28
EA006037B1 (ru) 2005-08-25
MA25775A1 (fr) 2003-07-01
EE200100682A (et) 2003-04-15
EA200200059A1 (ru) 2003-02-27
DK1194525T3 (da) 2006-09-18
PL352805A1 (en) 2003-09-08
JP5969764B2 (ja) 2016-08-17
ES2262522T3 (es) 2006-12-01
ITRM990400A0 (it) 1999-06-21
ITRM990400A1 (it) 2000-12-21
HUP0202051A3 (en) 2004-07-28
JP4949580B2 (ja) 2012-06-13
EE04620B1 (et) 2006-04-17
NO20016291L (no) 2002-02-20
DZ3167A1 (fr) 2000-12-28
NZ516022A (en) 2003-10-31
SK17172001A3 (sk) 2002-05-09
UA76696C2 (uk) 2006-09-15
CN1227354C (zh) 2005-11-16
IL146889A (en) 2009-11-18
JP6043325B2 (ja) 2016-12-14
WO2000078322A3 (en) 2001-06-28
HK1047132A1 (en) 2003-02-07
ATE325614T1 (de) 2006-06-15
AU775452B2 (en) 2004-08-05
AR024579A1 (es) 2002-10-16
CA2373375C (en) 2014-01-14
CA2373375A1 (en) 2001-11-27
AR086677A2 (es) 2014-01-15
IN2001KO01233A (de) 2006-03-17
IL146889A0 (en) 2002-08-14
BRPI0017622B1 (pt) 2016-12-06
MXPA01013239A (es) 2004-06-03
EP1194525A2 (de) 2002-04-10
HK1047132B (zh) 2006-04-13
WO2000078322A2 (en) 2000-12-28
ZA200200461B (en) 2002-09-25
TR200103606T2 (tr) 2002-04-22
JP2015043775A (ja) 2015-03-12
BRPI0011799B1 (pt) 2016-12-20
US7052688B2 (en) 2006-05-30
AU5566000A (en) 2001-01-09

Similar Documents

Publication Publication Date Title
DE60027894D1 (de) Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE251903T1 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69913520D1 (de) Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten
DE60109589D1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
DE60140377D1 (de) Mch antagonisten und deren verwendung zur behandlung von fettleibigkeit
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
EP1085892A4 (de) Impfstrategie zur vorbeugung und behandlung von krebs
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
EP1117395A4 (de) Verbindungen zur behandlung von östrogenabhängigen erkrankungen und deren herstellungs und verwendungsmethoden
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE60017133D1 (de) Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
DE60018591D1 (de) Milchsäurebakterien zur behandlung und prophylaxe von giardiasis
DE50111926D1 (de) Strahlungsanordnung sowie deren Verwendung und Verfahren zur Behandlung von Oberflächen
DE69912670D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
ATE418552T1 (de) Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
ATE299371T1 (de) Antikonvulsiva zur behandlung von autismus
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
DE60036723D1 (de) Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
EP1330271A4 (de) Verwendung von transkriptionsfaktoren zur behandlung von entzündungen und anderen erkrankungen
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
EP1233967A4 (de) Pyridinone zur behandlung und vorbeugung bakterieller infektionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition